{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:36:21Z","timestamp":1790832981560,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.euf.2017.08.007","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T21:05:31Z","timestamp":1504731931000},"page":"924-936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Gender-specific Differences in Recurrence of Non\u2013muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7305-9271","authenticated-orcid":false,"given":"Annemarie","family":"Uhlig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Seif Amir Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Lotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Trojan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2017.08.007_bib0005","unstructured":"Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer Incidence and mortality worldwide: IARC Cancer Base No. 11, Lyon, France, 2013. http:\/\/globocan.iarc.fr\/."},{"key":"10.1016\/j.euf.2017.08.007_bib0010","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0015","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0020","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","article-title":"A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder","volume":"325","author":"Lamm","year":"1991","journal-title":"N Engl J Med"},{"issue":"6 Pt 1","key":"10.1016\/j.euf.2017.08.007_bib0025","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.ju.0000125486.92260.b2","article-title":"A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials","volume":"171","author":"Sylvester","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0030","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.eururo.2009.01.006","article-title":"Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study","volume":"55","author":"Gudjonsson","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0035","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.eururo.2013.11.040","article-title":"Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients","volume":"66","author":"Kluth","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0040","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.genm.2012.11.001","article-title":"Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder","volume":"9","author":"Otto","year":"2012","journal-title":"Gender Med"},{"issue":"40","key":"10.1016\/j.euf.2017.08.007_bib0045","first-page":"e23","article-title":"Sex differences in incidence and mortality of bladder and kidney cancers: national estimates from 49 countries","volume":"32","author":"Donsky","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2017.08.007_bib0050","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0090-4295(00)00523-9","article-title":"Gender differences in stage-adjusted bladder cancer survival","volume":"55","author":"Mungan","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.euf.2017.08.007_bib0055","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin: multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0060","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00345-012-0996-9","article-title":"Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder","volume":"31","author":"Kluth","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0065","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1442-2042.2008.02235.x","article-title":"Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999\u20132001 report from the Japanese Urological Association","volume":"16","author":"Kikuchi","year":"2009","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/00365590802016302","article-title":"Risk factors for local recurrence in patients with pTa\/pT1 urinary bladder cancer","volume":"42","author":"Jancke","year":"2008","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.euf.2017.08.007_bib0075","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta7270","article-title":"Evaluating non-randomised intervention studies","volume":"7","author":"Deeks","year":"2003","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.euf.2017.08.007_bib0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"J Epidemiol Commun Health"},{"key":"10.1016\/j.euf.2017.08.007_bib0085","first-page":"40","article-title":"An R package for meta-analysis","volume":"7","author":"Schwarz","year":"2007","journal-title":"R News"},{"key":"10.1016\/j.euf.2017.08.007_bib0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1442-2042.2003.00559.x","article-title":"Clinical outcome of conservative therapy for stage T1, grade 3 transitional cell carcinoma of the bladder","volume":"10","author":"Hara","year":"2003","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10147-006-0562-9","article-title":"The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer","volume":"11","author":"Nonomura","year":"2006","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.euf.2017.08.007_bib0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00432-014-1795-z","article-title":"Selection of adjuvant intravesical therapies using the European Organization for Research and Treatment of Cancer scoring system in patients at intermediate risk of non-muscle-invasive bladder cancer","volume":"141","author":"Ofude","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.euf.2017.08.007_bib0105","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1442-2042.2006.01562.x","article-title":"Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ","volume":"13","author":"Sakai","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1442-2042.1997.tb00160.x","article-title":"Recurrence of primary superficial bladder cancer treated with prophylactic intravesical Tokyo 172 bacillus Calmette-Guerin: a long-term follow-up","volume":"4","author":"Shinka","year":"1997","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1464-410X.2004.04884.x","article-title":"Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection","volume":"94","author":"Mitsumori","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2017.08.007_bib0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1464-410X.2009.09137.x","article-title":"The effect of gender on response to bacillus Calmette-Guerin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder","volume":"106","author":"Boorjian","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2017.08.007_bib0125","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/cncr.28147","article-title":"Recurrence of high-risk bladder cancer: a population-based analysis","volume":"119","author":"Chamie","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2017.08.007_bib0130","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/cncr.23627","article-title":"Maintenance bacillus Calmette-Guerin in high-risk nonmuscle-invasive bladder cancer: how much is enough?","volume":"113","author":"Decobert","year":"2008","journal-title":"Cancer"},{"issue":"2 Pt 1","key":"10.1016\/j.euf.2017.08.007_bib0135","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/01.ju.0000103100.22951.5e","article-title":"Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5\u2009cm","volume":"171","author":"Donat","year":"2004","journal-title":"Urol"},{"issue":"4 Pt 1","key":"10.1016\/j.euf.2017.08.007_bib0140","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.juro.2007.05.148","article-title":"Management of low grade papillary bladder tumors","volume":"178","author":"Herr","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0145","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.eururo.2012.05.050","article-title":"Polyamine-modulated factor-1 methylation predicts bacillus Calmette-Guerin response in patients with high-grade non-muscle-invasive bladder carcinoma","volume":"63","author":"Alvarez-Mugica","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.urology.2016.01.004","article-title":"\u201cEn bloc\u201d resection of nonmuscle invasive bladder cancer: a prospective single-center study","volume":"90","author":"Hurle","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.euf.2017.08.007_bib0155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/21681805.2013.864327","article-title":"Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer","volume":"48","author":"Jancke","year":"2014","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0160","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3109\/21681805.2014.1000963","article-title":"Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study","volume":"49","author":"Liedberg","year":"2015","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0165","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/1471-2407-12-459","article-title":"Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer","volume":"12","author":"Otto","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euf.2017.08.007_bib0170","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.juro.2011.07.070","article-title":"Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors","volume":"186","author":"Pellucchi","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0175","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.acuro.2013.10.010","article-title":"Influence of the true number of bacillus Calmette-Guerin instillations on the prognosis of non-muscle invasive bladder tumors","volume":"38","author":"Portillo","year":"2014","journal-title":"Acta Urol Esp"},{"key":"10.1016\/j.euf.2017.08.007_bib0180","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.eururo.2011.07.010","article-title":"Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer","volume":"60","author":"Lammers","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eururo.2013.08.034","article-title":"Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladder","volume":"65","author":"Rieken","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0190","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1464-410X.2012.10996.x","article-title":"Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer","volume":"110","author":"van Rhijn","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2017.08.007_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2016.10.021","article-title":"Preoperative anemia is associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer","volume":"35","author":"Soria","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2017.08.007_bib0200","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.urolonc.2008.10.018","article-title":"Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey","volume":"28","author":"Nieder","year":"2010","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2017.08.007_bib0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/00365598309180162","article-title":"Presenting symptoms, treatment delay and survival in bladder cancer","volume":"17","author":"Mommsen","year":"1983","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.euf.2017.08.007_bib0210","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/00365599309180448","article-title":"Time lag to diagnosis of bladder cancer\u2014influence of psychosocial parameters and level of health-care provision","volume":"27","author":"Mansson","year":"1993","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.euf.2017.08.007_bib0215","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1002\/cncr.25310","article-title":"Delays in diagnosis and bladder cancer mortality","volume":"116","author":"Hollenbeck","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2017.08.007_bib0220","doi-asserted-by":"crossref","first-page":"27325","DOI":"10.18632\/oncotarget.8756","article-title":"Targeting estrogen\/estrogen receptor alpha enhances bacillus Calmette-Guerin efficacy in bladder cancer","volume":"7","author":"Shang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.euf.2017.08.007_bib0225","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0022-5347(05)67678-1","article-title":"Autocrine IL-6 production by human transitional carcinoma cells upregulates expression of the alpha5beta1 firbonectin receptor","volume":"163","author":"Zhang","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0230","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.juro.2010.09.004","article-title":"The effects of physiological estrogen concentration on the immune response of urothelial carcinoma cells to bacillus Calmette-Guerin","volume":"185","author":"Guise","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0235","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI114434","article-title":"Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response","volume":"85","author":"Kavoussi","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.euf.2017.08.007_bib0240","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.juro.2011.12.114","article-title":"Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumors","volume":"187","author":"Herkommer","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0245","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5489\/cuaj.2927","article-title":"Is there a gender effect in bladder cancer? A population-based study of practice and outcomes","volume":"9","author":"Patafio","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.euf.2017.08.007_bib0250","doi-asserted-by":"crossref","first-page":"668","DOI":"10.21037\/tau.2016.03.22","article-title":"Female with bladder cancer: what and why is there a difference?","volume":"5","author":"Marks","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0255","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1530\/ERC-15-0209","article-title":"The emerging role of the androgen receptor in bladder cancer","volume":"22","author":"Lombard","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.euf.2017.08.007_bib0260","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","article-title":"Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes","volume":"69","author":"Dobruch","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0265","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00345-013-1037-z","article-title":"Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity","volume":"31","author":"Gakis","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2017.08.007_bib0270","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/j.1464-410X.2011.10706.x","article-title":"Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder","volume":"109","author":"Miyamoto","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2017.08.007_bib0275","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1002\/cncr.21945","article-title":"Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue","volume":"106","author":"Shen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2017.08.007_bib0280","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/aje\/kwj028","article-title":"Hormonal and reproductive factors and the risk of bladder cancer in women","volume":"163","author":"McGrath","year":"2006","journal-title":"Am J Epidemiol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456917301992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456917301992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:48:45Z","timestamp":1762498125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456917301992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2405456917301992"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2017.08.007","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gender-specific Differences in Recurrence of Non\u2013muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2017.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}